Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures

We are now in an era of molecular medicine, where specific DNA alterations can be used to identify patients who will respond to specific drugs. However, there are only a handful of clinically used predictive biomarkers in oncology. Herein, we describe an approach utilizing in vitro DNA and RNA seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Rydzewski, Nicholas R., Peterson, Erik, Lang, Joshua M., Yu, Menggang, Laura Chang, S., Sjöström, Martin, Bakhtiar, Hamza, Song, Gefei, Helzer, Kyle T., Bootsma, Matthew L., Chen, William S., Shrestha, Raunak M., Zhang, Meng, Quigley, David A., Aggarwal, Rahul, Small, Eric J., Wahl, Daniel R., Feng, Felix Y., Zhao, Shuang G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455625/
https://www.ncbi.nlm.nih.gov/pubmed/34548481
http://dx.doi.org/10.1038/s41525-021-00239-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455625/
https://www.ncbi.nlm.nih.gov/pubmed/34548481
http://dx.doi.org/10.1038/s41525-021-00239-z

Ejemplares similares